lumacaftor/ivacaftor | |
---|---|
Trade Name | Orkambi |
Orphan Indication | Cystic fibrosis |
USA Market Approval | USA |
USA Designation Date | 2014-06-30 00:00:00 |
Sponsor | Vertex Pharmaceuticals Inc.;50 Northern Avenue;Boston, Massachusetts, 02210 |
Related Access Program